OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 14, 2025
The company plans to add 16,000 pallet spaces to the 13,000 it already has on site, making for a total of 68,000 pallet spaces covering various temperature requirements.
March 13, 2025
The multi-year strategic partnership is intended to support commercial demand of Viking Therapeutics’ GLP-1 candidate, VK2735.
March 11, 2025
The company’s 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.
March 10, 2025
The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.
March 07, 2025
The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.
March 06, 2025
More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.
March 05, 2025
The company first announced its intention to build the state-of-the-art facility as part of a €900 million investment in July 2024.
March 04, 2025
The company now performs product-sterility testing through rapid microbiological methods at two laboratory sites in the United States and one in Germany.
February 26, 2025
Contract manufacturers have special expertise in the characterization and validation of biopharmaceutical manufacturing processes.
February 25, 2025
Sponsor companies and contract development and manufacturing companies must ensure that the suppliers they use are following sustainability guidelines to truly produce ‘green’ products.